Not finding it? Sign in to also search OpenAlex live.
-
Central Nervous System Disorders (CNSD) Following Hematopoietic Stem Cell Transplantation (HSCT): A Prospective Study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP), European Society of Blood and Marrow Transplantation (EBMT)
Martin Schmidt‐Hieber, Per T Ljungman, Nina Simone Knelange, Joanna Ewa Drozd-Sokolowska, Grzegorz Władysław Basak, Hermann Einsele, +20 more
0citations -
Finerenone Added to Renin-Angiotensin System (RAS)/SGLT2 Blockade for Non-Diabetic CKD: Results of a Preclinical Randomized Controlled Trial2023 Journal of the American Society of Nephrology conference-abstract Medicine Chronic Kidney Disease and Diabetes
Zhihui Zhu, Yoshihiro Kusunoki, Chenyu Li, Martin Klaus, Peter Boor, Paola Romagnani, +1 more
0citations -
Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial
Hartmut Goldschmidt, Eva Nievergall, Roland R. Fenk, Uta Bertsch, Diana Tichy, Britta Besemer, +25 more
33citations -
Monotherapy Treatment with Zaltenibart (OMS906), an Alternative Pathway Masp-3 Inhibitor, Improved Key Hematologic Parameters in Patients with PNH with a Suboptimal Response to Ravulizumab: Interim Results from a Phase 2 Proof-of-Concept Study
Morag Griffin, Richard J. Kelly, Mathilde Gavillet, Petra Muus, Britta Hoechsmann, W. Jason Cummings, +4 more
4citations -
Apply-PNH: Analysis of complement pathway biomarkers provides evidence for pharmacodynamic response in PNH patients who receive oral iptacopan monotherapy versus continuing anti-C5 therapy2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Régis Peffault de Latour, Richard Kelly, Austin Gladston Kulasekararaj, Alexander Röth, Phillip Scheinberg, Yasutaka Ueda, +4 more
0citations -
Real-World Clinical Outcomes for Complement Inhibitor Experienced and Naïve Paroxysmal Nocturnal Hemoglobinuria Patients Prescribed Pegcetacoplan in Europe and Canada2024 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Jens Panse, Juan Carlos Vallejo Llamas, Koo Wilson, Zalmaï Hakimi, Barbara Czech, Sam Williamson, +4 more
1citations -
Direct Observation of Solid-Phase Crystallization of an Amorphous Complex Oxide in the Transmission Electron Microscope2023 ECS Meeting Abstracts conference-abstract Materials Science Advancements in Solid Oxide Fuel Cells
Jenna L. Wardini, George Frederick Harrington, Dennis Kemp, Roger A. De Souza, William J. Bowman
0citations -
Specific Gut Microbiome Changes in Myelodysplastic Neoplasms Linked to Inflammation2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Gut microbiota and health
Ekaterina Balaian, Katja Sockel, Manja Wobus, Maria Uhlig, Matthias Wolfgang Groß, Sebastian Zeißig, +3 more
2citations -
ABS0413 LET'S ASK THE PATIENT: DISEASE PREDICTION BASED ON FREE-TEXT SYMPTOM DESCRIPTIONS2025 Annals of the Rheumatic Diseases conference-abstract Health Professions Artificial Intelligence in Healthcare Open access
Inés Pérez-Sancristóbal, Nils Steinz, Tjardo Daniël Maarseveen, Floor Dijkstra Zegers, Barbara Bislawska Axnäs, Luis Rodríguez‐Rodríguez, +1 more
0citations -
Safety, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary efficacy of AZD2936, a bispecific antibody targeting PD-1 and TIGIT, in checkpoint inhibitor (CPI)-experienced advanced/metastatic non-small-cell lung cancer (NSCLC): First report of ARTEMIDE-01.2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Kristoffer Staal Rohrberg, Mariana Brandão, Eduardo Castañón Álvarez, Enriqueta Felip, Eelke Hiddo Gort, T. Jeroen N. Hiltermann, +14 more
22citations -
Phase 2 Study of Daratumumab (DARA) Plus Bortezomib, Cyclophosphamide, and Dexamethasone (D-VCd) in a Diverse Patient Population with Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Aquarius2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Michael Alan Rosenzweig, Yvonne Adeduni Efebera, Efstathios Kastritis, Brandon Jamaal Blue, Faizi A. Jamal, Monique C. Minnema, +10 more
1citations -
Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study2020 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +15 more
2citations -
Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study
Selim Corbacioglu, Jarl Mooyaart, Emmanuelle Polge, William Boreland, Jessica Lemaitre, Christophe Peczynski, +20 more
2citations -
664. ENHANCING RESILIENCE IN LEVERAGING DIGITAL THERAPEUTICS, AI, AS GOLDEN HOUR OPPORTUNITIES FOR PERSONALIZED INTERVENTIONS IN PREVENTION AND TREATMENT OF PTSD0citations
-
P-317: Integrated screening for type 1 diabetes and celiac disease: preliminary results of the SCREEND1A pilot program in Spain2026 Hormone Research in Paediatrics conference-abstract Biochemistry, Genetics and Molecular Biology Diabetes and associated disorders Open access
M Gonzalez-Arceo, X Irusta, I Urrutia, R Martinez, B Calvo, N Trebolazabala, +10 more
0citations
24 results